Simple external cues, such as lines on the floor, can help Parkinson’s patients focus their efforts and overcome the ...

Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...

Managing patients with Parkinson's disease should be viewed as part of a hospital CMO's responsibility for patient safety and ...

Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...

Parkinson’s disease is a challenging condition that affects millions of people around the world. It is known for causing ...

An Oxford study has shown how data could be used to predict the risk of falls in people with Parkinson’s disease.

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 4, 2024 — A ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...